Patterns of Influenza Vaccination and Vaccine Effectiveness Among Young US Children Who Receive Outpatient Care for Acute Respiratory Tract Illness

Abstract

IMPORTANCEThe burden of influenza among young children is high, and influenza vaccination is the primary strategy to prevent the virus and its complications. Less is known about differences in clinical protection following 1 vs 2 doses of initial influenza vaccination.OBJECTIVES To describe patterns of influenza vaccination among young children who receive outpatient care for acute respiratory tract illness in the US and compare vaccine effectiveness (VE) against medically attended laboratory-confirmed influenza by number of influenza vaccine doses received.DESIGN This test-negative case-control study was conducted in outpatient clinics, including emergency departments, at 5 sites of the US Influenza Vaccine Effectiveness Network during the 2014-2015 through 2017-2018 influenza seasons. The present study was performed from November 5, 2014, to April 12, 2018, during periods of local influenza circulation. Children aged 6 months to 8 years with an acute respiratory tract illness with cough who presented for outpatient care within 7 days of illness onset were included. All children were tested using real-time, reverse-transcriptase polymerase chain reaction for influenza for research purposes.EXPOSURES Vaccination in the enrollment season with either 1 or 2 doses of inactivated influenza vaccine as documented from electronic medical records, including state immunization information systems. MAIN OUTCOMES AND MEASURESMedically attended acute respiratory tract infection with real-time, reverse-transcriptase polymerase chain reaction testing for influenza. RESULTSOf 7533 children, 3480 children (46%) were girls, 4687 children (62%) were non-Hispanic white, and 4871 children (65%) were younger than 5 years. A total of 3912 children (52%) were unvaccinated in the enrollment season, 2924 children (39%) were fully vaccinated, and 697 children (9%) were partially vaccinated. Adjusted VE against any influenza was 51% (95% CI, 44%-57%) among fully vaccinated children and 41% (95% CI, 25%-54%) among partially vaccinated children. Among 1519 vaccine-naive children aged 6 months to 2 years, the VE of 2 doses in the enrollment season was 53% (95% CI, 28%-70%), and the VE of 1 dose was 23% (95% CI, −11% to 47%); those who received 2 doses were less likely to test positive for influenza compared with children who received only 1 dose (adjusted odds ratio, 0.57; 95% CI, 0.35-0.93).CONCLUSIONS AND RELEVANCE Consistent with US influenza vaccine policy, receipt of the recommended number of doses resulted in higher VE than partial vaccination in 4 influenza seasons. Efforts to improve 2-dose coverage for previously unvaccinated children may reduce the burden of influenza in this population.

Drivers of Infectious Disease Seasonality: Potential Implications for COVID-19

“…We propose that such research should complement current efforts to understand climatic and behavioral drivers of infectious disease seasonality. Even in the absence of host adaptations, seasonal predictability of diseases has major advantages for medical applications ( Kissler et al, 2020 ), as evidenced by the success of seasonal influenza vaccination campaigns ( Chung et al, 2020 ). To the extent that host physiology, too, is seasonal, such consistent patterns can be further exploited, analogous to the growing importance of circadian research for medical intervention.…”

Title: Clinical Manifestations and Outcome of Viral Acute Lower Respiratory Infection in Hospitalised Children in Myanmar

“…premature infants ≤35 weeks gestational age with chronic lung disease of prematurity and congenital heart disease) (86). Similarly, in uenza vaccines can prevent hospitalisation due to in uenza in children (87,88). Thus, the strengthening of prevention programs will improve the health of children in Myanmar, though further studies are needed to clarify the effectiveness of these prevention interventions in Myanmar.…”

Influenza’s plummeting and future dynamics: the roles of mask wearing, mobility change and SARS-CoV-2 interference

“…Given the relatively small cost on society 26,27 , wearing mask for a short period could be considered as an accompanying method to influenza vaccination in preparedness for influenza pandemics or severe seasonal epidemics, in populations at higher risk for developing severe complications or having lower vaccine efficacy 17,28 . Finally, the insight from our study could offer a head start on understanding SARS-CoV-2 interference in influenza transmission.…”